Japan Plasmid Dna Manufacturing Market Size & Outlook
Japan plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
Japan plasmid dna manufacturing market highlights
- The Japan plasmid dna manufacturing market generated a revenue of USD 72.6 million in 2024 and is expected to reach USD 235.3 million by 2030.
- The Japan market is expected to grow at a CAGR of 22.1% from 2025 to 2030.
- In terms of segment, gmp grade was the largest revenue generating grade in 2024.
- GMP Grade is the most lucrative grade segment registering the fastest growth during the forecast period.
Plasmid dna manufacturing market data book summary
| Market revenue in 2024 | USD 72.6 million |
| Market revenue in 2030 | USD 235.3 million |
| Growth rate | 22.1% (CAGR from 2025 to 2030) |
| Largest segment | Gmp grade |
| Fastest growing segment | GMP Grade |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | R&D Grade, GMP Grade |
| Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
Other key industry trends
- In terms of revenue, Japan accounted for 3.4% of the global plasmid dna manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 388.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Manufacturing Market Scope
Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 103.72% in 2024. Horizon Databook has segmented the Japan plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is anticipated to account for a significant share of the Asia Pacific plasmid DNA manufacturing market, as it has one of the most developed pharmaceutical and biotechnology sectors in the region.
Moreover, the high prevalence of chronic diseases and COVID-19 pandemic has led to increase in R&D activities for the development of novel therapies and vaccines, creating high demand for pDNA manufacturing solutions for research purposes.
Osaka University & AnGes Inc. developed this vaccination by combining their findings from producing DNA plasmid products. Similarly, in May 2020, Cytiva collaborated with Takara Bio to develop and manufacture a DNA vaccine candidate for COVID-19.
Reasons to subscribe to Japan plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan plasmid dna manufacturing market databook
-
Our clientele includes a mix of plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Japan plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan plasmid dna manufacturing market size, by grade, 2018-2030 (US$M)
Japan Plasmid DNA Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
